IP Library Granted Patent US 10,610,594
Granted Patent B2
US 10,610,594 · App. 14/442,693 · Granted Apr 7, 2020

BPO wash gel composition

Inventors: Karine Nadau-Fourcade (Villeneuve-Loubet, FR); Fabienne Louis (Villeneuve-Loubet, FR); Laetitia Mazeau (Cagnes-sur-Mer, FR)
Assignee: GALDERMA S.A.
A61K47/24A61K8/042A61K8/27A61K8/365A61K8/38A61K8/466A61K8/602A61K8/63A61K8/90A61K9/06A61K9/122A61K31/327A61K47/12A61K47/36A61Q19/008
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,610,594
App. No.
14/442,693
Granted
Apr 7, 2020
Kind
B2
Abstract

A topical dermatological/pharmaceutical composition is described that includes BPO wherein the composition is a wash composition with desirable tolerance, stability and foaming properties. The composition can include: a) benzoyl peroxide (BPO); b) at least one mild surfactant selected from anionic and/or non-ionic surfactant classes; c) zinc gluconate; d) dipotassium glycyrrhizate; and e) at least one gelling agent. The composition is preferably in the form of an aqueous gel or an aqueous-alcoholic gel. Also described, is the use of such a composition for the treatment of dermatological disorders, and in particular in the treatment of acne.

Claims (28)

1. A topical wash composition comprising:

(a) benzoyl peroxide at a nonzero concentration of equal to or less than 5% w/w;

(b) at least one anionic and/or non-ionic surfactant selected from the group consisting of sodium lauroyl methyl isethionate, decyl glucoside, zinc coceth sulfate, sodium cocoyl isethionate, and C14-C16 α-olefinsulfonates;

(c) zinc gluconate; and

(d) dipotassium glycyrrhizate;

wherein at least 90% of the benzoyl peroxide in the composition remains in the composition after storage at 40° C. for one to two months.

2. The composition according to claim 1 , wherein the composition is a foaming composition.

3. The composition according to claim 1 , wherein the composition further comprises at least one gelling agent selected from the group consisting of gelling agents in the polyacrylamide family, “electrolyte-insensitive” carbomers, polysaccharides, cellulose derivatives, bentonite, magnesium aluminium silicates, neutralized polymeric sulfonic acid and mixtures thereof.

4. The composition according to claim 1 , wherein the composition comprises between 1% w/w and 5% w/w of benzoyl peroxide.

5. The composition according to claim 3 , wherein the gelling agent is a polysaccharide, a magnesium aluminium silicate or a mixture thereof.

6. The composition according to claim 5 , wherein the gelling agent is a xanthan gum, a magnesium aluminium silicate or a mixture thereof.

7. The composition according to claim 1 , wherein the composition further comprises a wetting agent.

8. The composition according to claim 7 , wherein the wetting agent is a poloxamer and/or a glycol.

9. The composition according to claim 7 , wherein the wetting agent is propylene glycol, Poloxamer 124, or a mixture thereof.

10. The composition according to claim 7 , wherein the wetting agent is at a concentration between 1% to 7% by weight with regards to the total composition weight.

11. The composition according to claim 1 , wherein benzoyl peroxide is in dispersed form.

12. The composition according to claim 1 , wherein the composition comprises between 2.5% and 3.5% of benzoyl peroxide expressed by weight of active ingredient relative to the total weight of the composition.

13. The composition according to claim 1 , wherein the concentration of zinc gluconate expressed by weight relative to the total weight of the composition is between 0.15% and 0.3%.

14. The composition according to claim 1 , wherein dipotassium glycyrrhizate is present at a concentration expressed by weight relative to the total weight of the composition between 0.15% and 0.3%.

15. A method of improving, or inhibiting a dermatological condition linked to acne treatment, the method comprising administering an effective amount of the composition according to claim 1 to an individual subject in need thereof.

16. A method of treating acne, comprising administering to a subject in need thereof an effective amount of the composition according to claim 1 .

17. The method as defined in claim 16 , wherein the acne is common acne.

18. The composition according to claim 13 , wherein the concentration of the zinc gluconate is between 0.2% and 0.3% by weight, relative to the total weight of the composition.

19. The composition according to claim 14 , wherein the concentration of the dipotassium glycyrrhizate is between 0.25% and 0.3% by weight, relative to the total weight of the composition.

20. The composition of claim 1 , wherein the anionic and/or non-ionic surfactant is present at a concentration of between 0.5 and 5% by weight, relative to the total weight of the composition.

21. The composition of claim 1 , wherein the dipotassium glycyrrhizate is present at a concentration of between 0.1 to 1% by weight, relative to the total weight of the composition.

22. The composition of claim 1 , wherein the zinc gluconate is present at a concentration of between 0.1 and 1% by weight, relative to the total weight of the composition.

23. The composition of claim 3 , wherein the gelling agent is present at a concentration of between 0.15 and 7% by weight, relative to the total weight of the composition.

Assignments (4)
CHANGE OF ADDRESS Recorded Jun 28, 2022
From: GALDERMA HOLDING SA
To: GALDERMA HOLDING SA
Reel/Frame 060541/0374 →
ASSET TRANSFER AGREEMENT Recorded Oct 3, 2021
From: GALDERMA S.A.
To: NESTLÉ SKIN HEALTH S.A.
Reel/Frame 057698/0295 →
CHANGE OF NAME Recorded Oct 3, 2021
From: NESTLÉ SKIN HEALTH S.A.
To: GALDERMA HOLDING SA
Reel/Frame 057698/0356 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2015
From: NADAU-FOURCADE, KARINE; LOUIS, FABIENNE; MAZEAU, LAETITIA
To: GALDERMA S.A.
Reel/Frame 035844/0248 →
Cited By (1)
US 12,527,728